Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01175148 · ClinicalTrials.gov registry record · Phase 2
Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation
A Phase 2 study, sponsored by West Virginia University.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT01175148 is a Phase 2 study that has completed, run by West Virginia University. The registered enrollment target is 60 participants.
The verdict
NCT01175148, a Phase 2 study, has completed, sponsored by West Virginia University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
Atorvastatin for prevention of acute GVHD
Interventions
- DRUG Atorvastatin calcium (Lipitor)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-07 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01175148
The ClinicalTrials.gov registry entry for NCT01175148 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Atorvastatin calcium (Lipitor) is the first listed.
NCT01175148 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01175148 about?
NCT01175148 is a clinical study titled "Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation". Atorvastatin for prevention of acute GVHD
What is the current status of trial NCT01175148?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2010-07. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01175148?
The interventions under investigation include: Atorvastatin calcium (Lipitor) (DRUG).
Who is sponsoring clinical trial NCT01175148?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.